SCHEMBL23744780

SCHEMBL23744780

C#C[C@H]1CNC[C@H](C)N1c1ncc(C#N)cn1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
CHRM4 P08173 8/20 0.33
KDM1A O60341 1/20 0.32
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
JAK2 O60674 2/20 0.31
JAK1 P23458 2/20 0.31
TYK2 P29597 2/20 0.31
JAK3 P52333 2/20 0.31
EGLN2 Q96KS0 1/20 0.31
CHRNB2 P17787 2/20 0.30
CHRNA4 P43681 2/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23744679 0.87 HTR2A (0.46) HTR2AHTR2CHTR2BCHRM4KDM1A
SCHEMBL26087038 0.87 HTR2A (0.46) HTR2AHTR2CHTR2BCHRM4KDM1A
SCHEMBL23232139 0.72 IRAK4 (0.40) HTR2AHTR2CHTR2BJAK2JAK1
SCHEMBL23744326 0.71 ROCK2 (0.41) HTR2AHTR2CHTR2BJAK2JAK1
SCHEMBL23744678 0.71 ROCK2 (0.41) HTR2AHTR2CHTR2BJAK2JAK1
SCHEMBL2224273 0.71 KDM4E (0.50) HTR2AHTR2CHTR2BCHRM1JAK2
SCHEMBL23744494 0.69 CHRM4 (0.32) CHRM4KDM1ACHRM5CHRM1CHRM3
SCHEMBL23744665 0.65 ROCK2 (0.39) CHRM4KDM1ACHRM5CHRM1CHRM3
SCHEMBL23744666 0.65 ROCK2 (0.39) CHRM4KDM1ACHRM5CHRM1CHRM3
SCHEMBL23744674 0.65 ROCK2 (0.39) CHRM4KDM1ACHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158698-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-08-12 WO disclosed